Philips Evnia launches the 4th Gen QD-OLED Gaming Monitor, elevating the ultimate gaming experience, along with 4K 240Hz Refresh Rate and DP 2.1 Ports
Cutting-Edge Performance
The 27M2N8800 features a 27-inch 4K (3840x2160) 4th Gen QD-OLED panel, delivering unparalleled contrast, infinite blacks, and vibrant colors. With an ultra-fast 240Hz refresh rate and 0.03ms (GTG) response time, it eliminates motion blur and input lag, ensuring razor-sharp precision in fast-paced titles such as VALORANT and Call of Duty. The monitor's peak brightness of 1000 nits and VESA DisplayHDR True Black 400 certification create lifelike visuals, providing a true 10-bit color display and an ultra-wide color gamut for a immersive experience that brings vitality to your game.
Made for gaming
Equipped with DisplayPort 2.1 (80Gbps bandwidth) and dual HDMI 2.1 ports, the monitor supports uncompressed 4K 240Hz output, ideal for next-gen GPUs. A 10-bit color depth and 145% sRGB coverage ensure cinematic color reproduction, making every frame a masterpiece. Certified with AMD FreeSync™ Premium Pro, the monitor provides a variable refresh rate (VRR) and the true HDR gaming experience. combining smooth gameplay at peak performance with exceptionally high dynamic range visuals while maintaining low latency.
The built-in Evnia Precision Center software empowers gamers to fine-tune their experience:
•Stark Shadow Boost: the feature offers three selectable levels that enhance image texture with better color saturation and higher contrast, improving visibility in both light and dark environments.
•Smart Crosshair: the feature enhances aiming accuracy, allowing players to spot enemies more easily.
•Smart Sniper: Automatically zooms in on critical targets when scoping, perfect for landing clutch shots with agents like Jett.
A truly immersive visual experience
Philips Evnia exclusive Ai-enhanced Ambiglow feature is an innovative lighting technology that synchronizes RGB lights with audio and video content during gameplay. Located on the backside of the monitor, these lights interact with the game being played, changing color based on on-screen actions. This creates a more immersive experience, elevating gaming visuals to a new level.
Ergonomic Design and Unrivaled Warranty
In addition to its powerful visual and gaming features, the Philips Evnia 27M2N8800 prioritizes user comfort. The monitor's Height Adjustable Stand (HAS) allows for tilt, swivel, and height adjustments to fit the most comfortable position. Additionally, the Low Blue Mode reduces blue light exposure to the eyes, minimizing potential adverse health effects.
With all these features in mind, the Philips Evnia 27M2N8800 is an excellent choice for gamers seeking a powerful monitor with a visually competitive edge. For more information about the 27M2N8800, please visit .
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
3 days ago
- The Sun
InMobi Achieves 80% Penetration Among China's Top Gaming Publishers, Showcases Next-Gen Ad Innovation at ChinaJoy 2025
SHANGHAI, CHINA - Media OutReach Newswire - 1 August 2025 - InMobi, a global leader in mobile advertising and AI-powered monetization, is taking center stage at ChinaJoy 2025, highlighting its unparalleled growth and unwavering commitment to the Chinese developer ecosystem. With over 80% penetration among China's top 100 gaming publishers and near-complete publisher retention InMobi has acheived a two-fold increase in revenue for Chinese partners between H1 of 2024 and H1 of 2025. This impressive performance reinforces InMobi's position as a preferred global growth partner for mobile publishers. As Chinese apps continue to expand into global markets, InMobi is at the forefront of delivering the next generation of mobile experiences—offering high-impact, user-centric ad solutions and custom monetization strategies that drive measurable business outcomes. Attendees are invited to explore InMobi's latest innovations and client success stories at ChinaJoy 2025. Standing Out in a Competitive Landscape In the fast-evolving mobile advertising space, InMobi's full-stack ad platform—encompassing DSP, SSP, and owned-and-operated (O&O) media—distinguishes it from both local and international competitors. At the core of this differentiation is Helix AI, InMobi's proprietary intelligence engine that powers ad decision-making and optimization at scale. Supported by a dedicated team of local experts, InMobi enables Chinese developers to reach, acquire, and monetize high-value users efficiently across global markets. This distinct edge is delivering tangible results in the U.S. market. For instance, a leading gaming studio in China saw a 5% increase in ARPDAU for one of its top-performing titles after integrating InMobi's SDK. s Another fast-growing mobile games platform exceeded its ROAS targets and successfully acquired high-LTV users by leveraging Helix-powered campaign optimization capabilities. In an industry known for churn, InMobi has maintained a remarkable 90%+ client retention rate, underscoring the platform's reliability and value in the U.S. market. 'We're incredibly proud of the growth we've helped unlock for our Chinese partners,' said Kunal Nagpal, Chief Business Officer at InMobi. 'ChinaJoy is the perfect platform to showcase how our AI-driven solutions, global reach, and strong local presence are empowering developers to succeed on the world stage.' Strategic Vision and Product Innovation Looking ahead, InMobi is doubling down on its investment in China with a multi-faceted strategy that combines technological innovation, market expansion, and local expertise. At ChinaJoy 2025, InMobi is excited to announce the upcoming launch of Helix AI, its next-generation artificial intelligence engine that powers AcquirePro and Re-EngagePro—two core solutions designed to deliver smarter, data-driven user acquisition and re-engagement across global audiences. Simultaneously, InMobi's, associate company Glance, is expanding its Glance Ads offering, unlocking new monetization opportunities in India and Southeast Asia through platforms like Glance, Roposo, and Nostra. Earlier this year, Glance launched Glance AI, an AI commerce platform that creates an inspiration-led shopping experience for the emerging 'AI consumer.' The app is available in 140 countries and has been integrated with Motorola Edge phones in India and select Sharp models in Japan, with plans for further collaborations. Built on an open architecture, Glance AI transforms devices into smart commerce solutions and will soon expand into beauty and travel categories. To further strengthen its execution in China, InMobi has appointed Grace Gui as Head of DSP Business for China, ensuring that partners benefit from local strategic support backed by global scale. Visit InMobi at ChinaJoy InMobi welcomes all ChinaJoy attendees, where they can experience live demos of Helix AI, discover how InMobi is empowering Chinese developers accelerate global success, and engage with both the local leadership team and global product experts. The booth will serve as a hub for collaboration, strategic discussions, and innovation showcases—demonstrating how InMobi is redefining the mobile experience for both advertisers and users. InMobi's booth location:
The Sun
3 days ago
- The Sun
Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland
HONG KONG SAR - Media OutReach Newswire - 1 August 2025 - Cushman & Wakefield, a leading global real estate services firm, today released its Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland report. It is based on in-depth interview surveys we conducted on professionals active in the life sciences sector on the Chinese mainland. The life sciences industry on the Chinese mainland is undergoing a transformative phase, driven by progressive policies, groundbreaking innovations, the emergence of influential life sciences companies, and strategic regional development. This report delves into the latest trends shaping the sector. Policy Landscape – National and Local Catalysts Reforms enacted in 2024-2025 have significantly accelerated sector development. Nationally, China relaxed restrictions on foreign investment in gene and cell therapy and allowed the establishment of wholly foreign-owned hospitals in key cities. Regulatory incentives – such as data protection and marketing exclusivity – have improved market access for innovative drugs. Locally, cities like Beijing, Shanghai, Shenzhen, Guangzhou, and Suzhou are rolling out targeted subsidies, fast-track approvals, and ecosystem-building programmes that directly benefit biotech development. Recent national policy initiatives on the Chinese mainland Industry Innovation and Company Growth Chinese life sciences companies are moving beyond generic drug manufacturing toward innovative therapies. Firms like Akeso, BeiGene, Gracell, and Legend Biotech are now global players, leading in CAR-T, bispecific antibodies, and AI-assisted R&D. These companies are not only commercialising cutting-edge treatments but also attracting international investment and licensing agreements, reinforcing the Chinese mainland's global relevance in life sciences. Real Estate Development and Regional Hubs Innovation hubs such as Suzhou BioBAY, Zhangjiang Hi-Tech Park (Shanghai), and the Bioisland Innovation Centre (Guangdong) are central to regional clustering. These hubs offer end-to-end support, including shared labs, venture capital access, GMP-compliant facilities, and proximity to academic and clinical networks. The rise of second-tier innovation cities like Chengdu and Ningbo further expands growth corridors. The 'R&D + Manufacturing + Service' ecosystem Source: Cushman & Wakefield Research Landlord Perspectives – Evolving Real Estate Models Real estate developers and landlords are adapting to sector-specific requirements through asset-light models, flexible leasing, and high-specification lab and production space. Tier-1 cities face saturation, but central and western regions exhibit healthy demand. Developers are incorporating advanced sustainability and compliance features to meet growing regulatory and ESG expectations, particularly in GMP and cleanroom environments. Digitalisation, environmental policies, and differentiated tenant strategies are shaping performance. Operators now focus on integrated ecosystems with platforms that link tenants to R&D services, policy benefits, and technology partners. Occupier Perspectives – Growth, Innovation, and Challenges Life sciences occupiers are navigating regulatory reform, rising compliance demands, and intensified market competition. Many are localising production and R&D, leveraging regional subsidies, and investing in AI-powered innovation platforms. Occupiers seek flexibility, proximity to talent and infrastructure, and co-located R&D and manufacturing to support accelerated innovation and operational agility. In real estate, demand is strongest for GMP-certified labs, modular production facilities, and shared innovation platforms. Occupiers emphasise location advantages, sustainability certifications (e.g., LEED, WELL), and integration into clusters that enable faster time-to-market. Tony Su, Managing Director, National Head of Industrial & Logistics Property Services, China, said, 'Life sciences business parks on the Chinese mainland demonstrated clear regional differentiation, highlighting opportunities for strategic positioning. While Tier-1 cities saw more moderate performance due to broader macroeconomic factors and abundant supply, core cities in central and western regions recorded healthy occupancy rates, underpinned by strong industrial clustering and increasingly sophisticated ecosystems – contributing to steady growth in asset value.' Johnathan Wei, President, Project & Occupier Services, China, said, 'Several interviewed life sciences companies on the Chinese mainland achieved revenue growth supported by innovative products and favourable policy tailwinds. While overall growth remained modest for many, a select group reported strong performance, highlighting opportunities for differentiation'. Andrew Chan, Managing Director, Head of Valuation & Advisory Services, Greater China, said,' Looking ahead to 2025 and beyond, growth opportunities lie in AI-driven drug discovery, personalised medicine, advanced therapeutics (CGT, RNA), and green-certified facilities. Government policies continue to support innovation through fast-track approvals, rare disease funding, and subsidies aligned with dual-carbon and ESG goals'. Shaun Brodie, Head of Research Content, Greater China, 'Life sciences real estate is shifting from generic parks to specialised, digitally enabled campuses with high compliance and flexibility. Investment strategies increasingly emphasise long-term partnerships, collaborative operating models, and digital infrastructure. Both landlords and occupiers express cautious optimism, with strategic differentiation and regional targeting seen as keys to unlocking future value'. Please click here to download the full report.
The Sun
3 days ago
- The Sun
AI-Driven Cyber Attacks and Supply Chain Vulnerabilities Escalate Risk Landscape in Australia, Aon Report Finds
SYDNEY, AUSTRALIA - Media OutReach Newswire - 31 July 2025 - Aon plc (NYSE: AON), a leading global professional services firm, has released the Australia-specific findings from its 2025 Cyber Risk Report. The report highlights the growing impact of artificial intelligence (AI)-enabled cyber attacks and the increasing exposure created by third-party technology supply chains. The report reveals that Australian organisations are facing a new frontier of cyber risk, where traditional defences are being outpaced by the speed and sophistication of AI-driven threats. 'AI is no longer a future threat—it's a present-day reality,' said Adam Peckman, head of risk consulting and cyber solutions in APAC and global head of cyber risk consulting at Aon. 'We're seeing relatively unsophisticated actors now wielding tools that rival state-sponsored capabilities. The barrier to entry has dropped dramatically, and the velocity of attacks is only increasing.' One of the most concerning developments is the emergence of AI-powered social engineering attacks. Last year saw an incident involving the theft of USD $25 million from a large UK engineering firm through a deepfake-enabled scam—an attack that has since been replicated onshore in Australia at smaller financial scale. These incidents underscore the growing accessibility and replicability of such tactics. In addition to AI threats, the report identifies technology supply chains as a critical vulnerability. A number of high-profile Australian breaches have stemmed from third-party compromises, where attackers exploit weaker security standards in vendors with privileged access to client systems. 'Organisations must start treating their vendors as part of their own attack surface,' added Joerg Schmitz, Cyber Risk Quantification and Analytics Leader for APAC at Aon. 'The most lucrative attacks are those that can be scaled across multiple targets through a single compromised supplier. This is a wake-up call for Australian businesses to reassess how they manage third-party risk.' Despite continued investment in cyber security, the report warns that core controls are being circumvented or rendered obsolete by evolving tactics. The use of AI to optimise every stage of the attack chain—from reconnaissance to execution—demands a fundamental rethink of defensive strategies. Aon's 2025 Cyber Risk Report draws on CyQu data from over 3,000 clients globally and analyses more than 1,400 cyber events to identify emerging trends. The platform enables organisations to benchmark their cyber maturity, align insurance and security strategies, and make more informed, data-driven decisions. Aon's 2025 Cyber Risk Report can be found here. Hashtag: #Aon The issuer is solely responsible for the content of this announcement.
